Bipartisan legislation would require insurers to cover FDA-approved medications that significantly slow disease progression, ...

Researchers at Vanderbilt University's Warren Center for Neuroscience Drug Discovery have created the first selective ...

The U.S. Food and Drug Administration (FDA) recently approved Leqembi, a drug indicated to treat Alzheimer’s disease in patients with mild cognitive impairment. The FDA granted Leqembi an Accelerated ...

Alzheimer's disease has traditionally been studied as a condition that primarily affects the brain's gray matter, where neuronal cell bodies are located and some of the disease's most characteristic ...

A new era in dementia care has arrived in Australia following the Therapeutic Goods Administration’s (TGA) regulatory ...

Researchers created a 3D human brain tissue model using stem cells to model Alzheimer's plaque clearance and enable automated ...

Dan Schwinnen doesn’t see himself as particularly gullible, but in a desperate attempt to obtain some medical relief in his mother-in-law’s battle against Alzheimer’s Disease, he took a ...

A new study shows ImmunoBrain anti-PD-L1 antibody IBC-Ab002 is safe and reduces neurodegenerative biomarkers in Alzheimer's.

"Early ultrastructural investigations showed a prominent presence of degenerating mitochondria in the brain of patients with ...

A 2024 report of a severe Alzheimer's disease patient who improved after an intravenous mesenchymal stem cell transplant was ...

People who lived within 50 km of a coal-fired power plant were 72.9% more likely to develop Alzheimer’s disease pathology ...

Readers respond to a Science Times article, “New Potential for Diagnosing Alzheimer’s Disease.” Also: The noise that data centers make.